Skip to main content
Top
Published in: Clinical Research in Cardiology 3/2014

01-03-2014 | Original Paper

Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines

Authors: Renee Stark, Inge Kirchberger, Matthias Hunger, Margit Heier, Reiner Leidl, Wolfgang von Scheidt, Christa Meisinger, Rolf Holle

Published in: Clinical Research in Cardiology | Issue 3/2014

Login to get access

Abstract

Background

Cardiac disease management programmes (CHD-DMPs) and secondary cardiovascular prevention guidelines aim to improve complex care of post-myocardial infarction (MI) patients. In Germany, CHD-DMPs, in addition to incorporating medical care according to guidelines (guideline-care), also ensure regular quarterly follow-up. Thus, our aim was to examine whether CHD-DMPs increase the frequency of guideline-care and whether CHD-DMPs and guideline-care improve survival over 4 years.

Methods

The study included 975 post-MI patients, registered by the KORA-MI Registry (Augsburg, Germany), who completed a questionnaire in 2006. CHD-DMP enrolment was reported by physicians. Guideline-care was based on patient reports regarding medical advice (smoking, diet, or exercise) and prescribed medications (statins and platelet aggregation inhibitors plus beta-blockers or renin-angiotensin inhibitors). All-cause mortality until December 31, 2010 was based on municipal registration data. Cox regression analyses were adjusted for age, sex, education, years since last MI, and smoking and diabetes.

Results

Physicians reported that 495 patients were CHD-DMP participants. CHD-DMP participation increased the likelihood of receiving guideline-care (odds ratio 1.55, 95 % CI 1.20; 2.02) but did not significantly improve survival (hazard rate 0.90, 95 % CI 0.64–1.27). Guideline-care significantly improved survival (HR 0.41, 95 % CI 0.28; 0.59). Individual guideline-care components, which significantly improved survival, were beta-blockers, statins and platelet aggregation inhibitors. However, these improved survival less than guideline-care.

Conclusions

This study shows that CHD-DMPs increase the likelihood of guideline care and that guideline care is the important component of CHD-DMPs for increasing survival. A relatively high percentage of usual care patients receiving guideline-care indicate high quality of care of post-MI patients. Reasons for not implementing guideline-care should be investigated.
Literature
3.
go back to reference Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA (2006) AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113(19):2363–2372. doi:10.1161/CIRCULATIONAHA.106.174516 PubMedCrossRef Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA (2006) AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113(19):2363–2372. doi:10.​1161/​CIRCULATIONAHA.​106.​174516 PubMedCrossRef
6.
go back to reference Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F, European Association for Cardiovascular P, Rehabilitation, Guidelines ESCCfP (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth joint task force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33(13):1635–1701. doi:10.1093/eurheartj/ehs092 PubMedCrossRef Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F, European Association for Cardiovascular P, Rehabilitation, Guidelines ESCCfP (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth joint task force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33(13):1635–1701. doi:10.​1093/​eurheartj/​ehs092 PubMedCrossRef
7.
go back to reference Zeymer U, Junger C, Zahn R, Bauer T, Bestehorn K, Senges J, Gitt A (2011) Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach. Curr Med Res Opin 27(8):1563–1570. doi:10.1185/03007995.2011.590969 PubMedCrossRef Zeymer U, Junger C, Zahn R, Bauer T, Bestehorn K, Senges J, Gitt A (2011) Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach. Curr Med Res Opin 27(8):1563–1570. doi:10.​1185/​03007995.​2011.​590969 PubMedCrossRef
10.
go back to reference Miksch A, Laux G, Ose D, Joos S, Campbell S, Riens B, Szecsenyi J (2010) Is there a survival benefit within a German primary care-based disease management program? Am J Manag Care 16(1):49–54. doi:12562 PubMed Miksch A, Laux G, Ose D, Joos S, Campbell S, Riens B, Szecsenyi J (2010) Is there a survival benefit within a German primary care-based disease management program? Am J Manag Care 16(1):49–54. doi:12562 PubMed
11.
go back to reference Drabik A, Buscher G, Thomas K, Graf C, Muller D, Stock S (2012) Patients with type 2 diabetes benefit from primary care-based disease management: a propensity score matched survival time analysis. Popul Health Manag 15(4):241–247. doi:10.1089/pop.2011.0063 PubMedCrossRef Drabik A, Buscher G, Thomas K, Graf C, Muller D, Stock S (2012) Patients with type 2 diabetes benefit from primary care-based disease management: a propensity score matched survival time analysis. Popul Health Manag 15(4):241–247. doi:10.​1089/​pop.​2011.​0063 PubMedCrossRef
14.
go back to reference Kirchberger I, Heier M, Kuch B, Wende R, Meisinger C (2011) Sex differences in patient-reported symptoms associated with myocardial infarction (from the population-based MONICA/KORA Myocardial Infarction Registry). Am J Cardiol 107(11):1585–1589. doi:10.1016/j.amjcard.2011.01.040 PubMedCrossRef Kirchberger I, Heier M, Kuch B, Wende R, Meisinger C (2011) Sex differences in patient-reported symptoms associated with myocardial infarction (from the population-based MONICA/KORA Myocardial Infarction Registry). Am J Cardiol 107(11):1585–1589. doi:10.​1016/​j.​amjcard.​2011.​01.​040 PubMedCrossRef
15.
go back to reference Hostetter JC, Ghaffari S (2003) Should everyone with a recent myocardial infarction receive a beta-blocker and an ACE inhibitor? Clevel Clin J Med 70(1):46–48CrossRef Hostetter JC, Ghaffari S (2003) Should everyone with a recent myocardial infarction receive a beta-blocker and an ACE inhibitor? Clevel Clin J Med 70(1):46–48CrossRef
17.
go back to reference Horton NJ, Lipsitz SR (2001) Multiple imputation in practice: comparison of software packages for regression models with missing variables. Am Stat 55(3):244–254CrossRef Horton NJ, Lipsitz SR (2001) Multiple imputation in practice: comparison of software packages for regression models with missing variables. Am Stat 55(3):244–254CrossRef
18.
go back to reference Schunk M, Stark R, Reitmeir P, Rathmann W, Meisinger C, Holle R (2011) Improvements in type 2 diabetes care? Pooled analysis of survey data in southern Germany (KORA) from 1999-2008. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 54(11):1187–1196. doi:10.1007/s00103-011-1364-4 PubMedCrossRef Schunk M, Stark R, Reitmeir P, Rathmann W, Meisinger C, Holle R (2011) Improvements in type 2 diabetes care? Pooled analysis of survey data in southern Germany (KORA) from 1999-2008. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 54(11):1187–1196. doi:10.​1007/​s00103-011-1364-4 PubMedCrossRef
19.
go back to reference Stark RG, Schunk MV, Meisinger C, Rathmann W, Leidl R, Holle R, Grp KS (2011) Medical care of type 2 diabetes in German disease management programmes: a population-based evaluation. Diabetes Metab Res 27(4):383–391CrossRef Stark RG, Schunk MV, Meisinger C, Rathmann W, Leidl R, Holle R, Grp KS (2011) Medical care of type 2 diabetes in German disease management programmes: a population-based evaluation. Diabetes Metab Res 27(4):383–391CrossRef
20.
go back to reference Jolly K, Bradley F, Sharp S, Smith H, Thompson S, Kinmonth AL, Mant D (1999) Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. BMJ 318(7185):706–711PubMedCentralPubMedCrossRef Jolly K, Bradley F, Sharp S, Smith H, Thompson S, Kinmonth AL, Mant D (1999) Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. BMJ 318(7185):706–711PubMedCentralPubMedCrossRef
21.
go back to reference Khunti K, Stone M, Paul S, Baines J, Gisborne L, Farooqi A, Luan X, Squire I (2007) Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart 93(11):1398–1405. doi:10.1136/hrt.2006.106955 PubMedCentralPubMedCrossRef Khunti K, Stone M, Paul S, Baines J, Gisborne L, Farooqi A, Luan X, Squire I (2007) Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart 93(11):1398–1405. doi:10.​1136/​hrt.​2006.​106955 PubMedCentralPubMedCrossRef
22.
go back to reference Law MR, Watt HC, Wald NJ (2002) The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med 162(21):2405–2410PubMedCrossRef Law MR, Watt HC, Wald NJ (2002) The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med 162(21):2405–2410PubMedCrossRef
23.
go back to reference Kuch B, Heier M, von Scheidt W, Kling B, Hoermann A, Meisinger C (2008) 20-year trends in clinical characteristics, therapy and short-term prognosis in acute myocardial infarction according to presenting electrocardiogram: the MONICA/KORA AMI Registry (1985-2004). J Intern Med 264(3):254–264. doi:10.1111/j.1365-2796.2008.01956.x PubMedCrossRef Kuch B, Heier M, von Scheidt W, Kling B, Hoermann A, Meisinger C (2008) 20-year trends in clinical characteristics, therapy and short-term prognosis in acute myocardial infarction according to presenting electrocardiogram: the MONICA/KORA AMI Registry (1985-2004). J Intern Med 264(3):254–264. doi:10.​1111/​j.​1365-2796.​2008.​01956.​x PubMedCrossRef
24.
go back to reference McAlister FA, Lawson FM, Teo KK, Armstrong PW (2001) Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ 323(7319):957–962PubMedCentralPubMedCrossRef McAlister FA, Lawson FM, Teo KK, Armstrong PW (2001) Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ 323(7319):957–962PubMedCentralPubMedCrossRef
25.
go back to reference Murphy AW, Cupples ME, Smith SM, Byrne M, Byrne MC, Newell J (2009) Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial. BMJ 339:b4220. doi:10.1136/bmj.b4220 PubMedCentralPubMedCrossRef Murphy AW, Cupples ME, Smith SM, Byrne M, Byrne MC, Newell J (2009) Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial. BMJ 339:b4220. doi:10.​1136/​bmj.​b4220 PubMedCentralPubMedCrossRef
26.
go back to reference Bailey TC, Noirot LA, Gage BF, Li X, Shannon WD, Waterman B, Sinha S, Bouselli DA, Reichley RM, Goldberg AC, Dunagan WC (2006) Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital. AMIA Annual Symposium proceedings/AMIA Symposium AMIA Symposium:850 Bailey TC, Noirot LA, Gage BF, Li X, Shannon WD, Waterman B, Sinha S, Bouselli DA, Reichley RM, Goldberg AC, Dunagan WC (2006) Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital. AMIA Annual Symposium proceedings/AMIA Symposium AMIA Symposium:850
27.
go back to reference Tickoo S, Fonarow GC, Hernandez AF, Liang L, Cannon CP (2008) Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association’s get with the guidelines—coronary artery disease database). Am J Cardiol 102(6):663–667. doi:10.1016/j.amjcard.2008.04.053 PubMedCrossRef Tickoo S, Fonarow GC, Hernandez AF, Liang L, Cannon CP (2008) Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association’s get with the guidelines—coronary artery disease database). Am J Cardiol 102(6):663–667. doi:10.​1016/​j.​amjcard.​2008.​04.​053 PubMedCrossRef
28.
go back to reference Ctt C Cholesterol Treatment Trialists’ (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. doi:10.1016/S0140-6736(12)60367-5 Ctt C Cholesterol Treatment Trialists’ (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. doi:10.​1016/​S0140-6736(12)60367-5
29.
go back to reference Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665. doi:10.1136/bmj.b1665 PubMedCentralPubMedCrossRef Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665. doi:10.​1136/​bmj.​b1665 PubMedCentralPubMedCrossRef
30.
go back to reference Antithrombotic Trialists C, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373(9678):1849–1860. doi:10.1016/S0140-6736(09)60503-1 CrossRef Antithrombotic Trialists C, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373(9678):1849–1860. doi:10.​1016/​S0140-6736(09)60503-1 CrossRef
31.
go back to reference Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, Gomez-Gracia E, Ruiz-Gutierrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Basora J, Munoz MA, Sorli JV, Martinez JA, Martinez-Gonzalez MA, Investigators PS (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368(14):1279–1290. doi:10.1056/NEJMoa1200303 PubMedCrossRef Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, Gomez-Gracia E, Ruiz-Gutierrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Basora J, Munoz MA, Sorli JV, Martinez JA, Martinez-Gonzalez MA, Investigators PS (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368(14):1279–1290. doi:10.​1056/​NEJMoa1200303 PubMedCrossRef
33.
go back to reference Joos S, Rosemann T, Heiderhoff M, Wensing M, Ludt S, Gensichen J, Kaufmann-Kolle P, Szecsenyi J (2005) ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct—a study protocol [ISRCTN08471887]. BMC Public Health 5:99. doi:10.1186/1471-2458-5-99 PubMedCentralPubMedCrossRef Joos S, Rosemann T, Heiderhoff M, Wensing M, Ludt S, Gensichen J, Kaufmann-Kolle P, Szecsenyi J (2005) ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct—a study protocol [ISRCTN08471887]. BMC Public Health 5:99. doi:10.​1186/​1471-2458-5-99 PubMedCentralPubMedCrossRef
34.
go back to reference Azaouagh A, Churzidse S, Konorza T, Erbel R (2011) Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update. Clinical Res Cardiol Off J Ger Cardiac Soc 100(5):383–394. doi:10.1007/s00392-011-0295-2 CrossRef Azaouagh A, Churzidse S, Konorza T, Erbel R (2011) Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update. Clinical Res Cardiol Off J Ger Cardiac Soc 100(5):383–394. doi:10.​1007/​s00392-011-0295-2 CrossRef
35.
go back to reference Dabiri Abkenari L, Theuns DA, Valk SD, Van Belle Y, de Groot NM, Haitsma D, Muskens-Heemskerk A, Szili-Torok T, Jordaens L (2011) Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol Off J Ger Cardiac Soc 100(9):737–744. doi:10.1007/s00392-011-0303-6 CrossRef Dabiri Abkenari L, Theuns DA, Valk SD, Van Belle Y, de Groot NM, Haitsma D, Muskens-Heemskerk A, Szili-Torok T, Jordaens L (2011) Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol Off J Ger Cardiac Soc 100(9):737–744. doi:10.​1007/​s00392-011-0303-6 CrossRef
Metadata
Title
Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines
Authors
Renee Stark
Inge Kirchberger
Matthias Hunger
Margit Heier
Reiner Leidl
Wolfgang von Scheidt
Christa Meisinger
Rolf Holle
Publication date
01-03-2014
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 3/2014
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-013-0643-5

Other articles of this Issue 3/2014

Clinical Research in Cardiology 3/2014 Go to the issue